The Research and Training group of the Société Française d’Immunothérapie du Cancer (FITC) is organising its 2nd Seminar – Research in immuno-oncology!

This second session will be held on Friday 23 May from 1pm to 2pm and will focus on ‘Antibody-Drug Conjugates’ on Zoom.

We will be delighted to welcome Charles Dumontet (Hospices Civils de Lyon/Centre de Recherche en Cancérologie de Lyon), who will review the current state of knowledge and advances in the field of Antibody-Drug Conjugates, and Fernanda Mosele (Institut Gustave Roussy), who will present her work recently published in Nature Medicine on the mechanisms of action and resistance of Trastuzumab Deruxtecan in metastatic breast cancer.

This event is free of charge, but registration is compulsory: https://forms.gle/3z7DYnwsKDxKz7aJ8